News brief
According to AIPressRoom, on October 10, 2026, surgical robotics company Medical Microinstruments (MMI) closed a $125 million Series D round led by BioStar Capital. The funding accelerates commercialization of its Symani Surgical System in the US and international markets; roughly 50 systems are installed worldwide with about 3,500 complex microsurgical procedures completed.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- aipressroom.com ↗Published Oct 10, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
据AIPressRoom报道，2026年10月10日，手术机器人公司Medical Microinstruments（MMI）完成1.25亿美元D轮融资，由BioStar Capital领投。资金将用于其Symani手术系统在美国及国际市场的商业化推广，并支持全球扩张、临床研究与产品开发，目前全球已装机约50台、完成约3500例复杂显微手术。